Rare diseases
Investigational molecules
Locations
Back to Germany40 clinical trials in Bayreuth, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
GermanyEffect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury
GermanyPhase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer
GermanyA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
GermanyStudy of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks
GermanySafety and tolerability study of sodium hydrogen carbonate and sodium dihydrogen phosphate suppository treatment in adult patients with chronic constipation
GermanyStudy of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)
GermanyStudy on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
GermanyStudy on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hematologic malignancies and solid tumors, including studies on chronic myeloid leukemia, multiple myeloma, and various types of breast cancer.
Research emphasizes novel drug combinations and treatment strategies to improve patient outcomes.
Extensive research into multiple sclerosis treatments, including evaluations of new therapies and long-term safety studies of established medications.
Studies focus on both relapsing and progressive forms of neurological conditions.
Investigation of various treatment modalities including targeted therapies, immunotherapies, and combination treatments across multiple disease areas.
Focus on developing personalized treatment strategies and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
